1·This article reviews risedronate sodium in its pharmaco-mechanism, pharmacokinetics, clinical application and adverse reaction.
本文综述了利塞膦酸钠的药理作用，药代动力学，临床应用和不良反应。
2·OBJECTIVE: To study the pharmacokinetics and pharmacodynamics of verapamil in patients with hypertension.
目的：研究维拉·帕米在高血压患者的药代动力学及药效学。
3·Explain the pharmacodynamics and pharmacokinetics of a variety of drugs used to treat primary care conditions.
解释各种药物用于治疗的基层医疗条件的药效学和药代动力学。
4·Objective: To study the pharmacokinetics and relative bioavailability of domestic cetirizine hydrochloride capsule in healthy volunteers.
目的：研究国产盐酸西替利嗪胶囊的人体药代动力学和相对生物利用度。
5·Objective: to determine the safety, tolerability, and pharmacokinetics of increasing doses of idebenone in subjects with FA.
目的：测定fa患者中艾地苯醌加大剂量使用时的安全性，耐受性和药代动力学。
1·OBJECTIVE: To determine pharmacokinetics of tinidazole in patients with lung infection.
目的：测定肺部感染患者静脉注射替硝唑的药物动力学。
2·Objective: To establish the grey pharmacokinetics model of the fleetness intravenous infusion.
目的：建立快速推注的灰色药物动力学模型。
3·Conclusion: the method is sensitive and accurate, fit for the research of pharmacokinetics and pharmacodynamics.
结论：此方法灵敏、准确，适用于药物动力学和药效学研究。
4·ObjectiveTo investigate the pharmacokinetics and bioequivalence of domestic and imported nifedipine controlled release tablets.
目的研究国产和进口硝苯地平控释片的药物动力学和生物等效性。
5·Conclusion: the gray theories can be used for establishing the fleetness intravenous injection pharmacokinetics model.
结论：灰色理论可用于建立静脉注射药物动力学模型。